The Center for Data Driven Discovery in Biomedicine (D³b)

Welcome to The Center for Data-Driven Discovery in Biomedicine

Breakthroughs for every child, every time, everywhere

Which Best Describes Yourself?

  • Explorer
  • Government
  • Healthcare
  • Partners
  • Patients
  • Research

Explorer

Learn more about the research initiatives and breakthroughs happening every day throughout The Center for Data Driven Discovery in Biomedicine.  The center brings together leading clinical care professionals, data scientists, bioinformaticians and other researchers to discover cures and better therapeutics for children diagnosed with cancer and other diseases.

  • Explorer
    Explorer

    Chordoma Foundation Biobank

    Background The Chordoma Foundation (CF) biospecimens, clinical and genomic data via the expertise and tools created by the Center for Data Driven Discovery (D3b) at the Children’s Hospital…

  • Explorer
    Explorer

    Oligo Nation

    Oligodendroglioma Oligodendroglioma (Oligo) is a primary malignant brain cancer that develops from Oligodendrocytes. Oligodendroglioma is one of the more common types of glioma (which also includes Glioblastoma Multiforme…

  • Explorer
    Explorer

    Pario Group – Congenital Birth Defect Biobanking for Genetic Research

    Pario Group is a genetic research effort to store samples from cohorts of congenital birth defects in children in order to improve doctors’ abilities to assess the long-term…

  • Explorer
    Explorer

    Cole-Reagins Registry for Sinonasal Cancer (CORSICA)

    About CORSICA Funded by the Cole-Reagins Family Foundation after the death of a family member from sinus cancer, the Cole-Reagins Registry for Sinonasal Cancer (CORSICA) is a Stanford…

  • Explorer
    Explorer

    The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system

    Abstract PURPOSE: Clinicians and researchers must contextualize a patient’s genetic variants against population-based references with detailed phenotyping. We sought to establish globally scalable technology, policy, and procedures for…

  • Explorer
    Explorer

    Targeting PARP-1 with Alpha-Particles Is Potently Cytotoxic to Human Neuroblastoma in Preclinical Models

    Abstract Alpha-emitters can be pharmacologically delivered for irradiation of single cancer cells, but cellular lethality could be further enhanced by targeting alpha-emitters directly to the nucleus. PARP-1 is…